Patients who underwent transplantation were not censored at the time of transplant.
Moreover, the speed of relapse depends on both the MM population at the time of transplant as well as the degree of tumour cytoreduction achieved with transplantation.
The mean time of transplant evolution to the time of reduction was 9.9 ± 11.8 months.
Forty-one patients had active leukemia at the time of transplant, and 35 achieved CR (85%).
At the time of transplant lettuce seedlings showed only differences in green colour intensity measured by SPAD, which was higher in GM (20.3) that in Pt (18.7).
Transplant of one C57Bl/6 donor kidney into Balb/c mice with recipient mouse kidneys removed at time of transplant, causes early mortality with a median survival of 22.7±8.1 days after treatment (Fig. 4A).
Infusion of host-type Th2.R cells one week pre-transplant optimally promoted host Th2-type immunity at the time of transplant and preserved allograft viability in 100% of recipients.
Three patients had active disease at the time of transplant.
Informed consent was obtained at the time of transplant evaluation.
At the time of transplant, 13 of the 31 patients (42%) were considered to have CR.
The majority of patients had advanced disease at the time of transplant (17/27 or 63%).
